Journal of Legal Medicine ( IF 0.417 ) Pub Date : 2021-04-02 , DOI: 10.1080/01947648.2020.1868940 Desmond Jenson
Abstract
In the 10 years that the U.S. Food and Drug Administration (FDA) has been regulating tobacco products, the agency has been plagued with setbacks, some of its own making, and some the result of outside forces. What has been consistently true is that the public health community has not had as much of a voice as it should have until public health groups began filing lawsuits against the FDA. This article examines four areas of FDA regulation over the last decade in an attempt to qualitatively describe the work of the Center for Tobacco Products and identify opportunities for public health groups to have greater advocacy success in the future.
中文翻译:

FDA烟草监管十年:公共卫生利益相关者的经验教训
摘要
在美国食品药品监督管理局(FDA)监管烟草产品的10年中,该机构一直遭受挫折,一些自己制造的产品以及一些外来因素的影响。一直以来的真实情况是,在公共卫生组织开始对FDA提起诉讼之前,公共卫生界没有应有的发言权。本文研究了过去十年来FDA监管的四个领域,以定性地描述烟草产品中心的工作,并确定公共卫生团体在未来获得更大宣传成功的机会。